4.1 Article

Development of a pO2-Guided Fine Needle Tumor Biopsy Device

出版社

ASME
DOI: 10.1115/1.4052900

关键词

tumor; hypoxia; diagnosis; phosphorescent probe; fine needle biopsy

资金

  1. National Institutes of Health, National Cancer Institute, (NIH-NCI) [HHSN261201400056C]

向作者/读者索取更多资源

Tumor biopsies play a crucial role in oncology for guiding medical treatment and evaluating disease progression. However, accessing reliable tumor tissue pathology is challenging due to the heterogeneous nature of tumors. Oxygen levels in tumor tissue provide valuable information, but there is a risk of acquiring non-diagnostic cells if the biopsy needle is placed in normal tissue. A pO(2)-guided biopsy needle has been developed to determine oxygen levels and fluctuations in highly resolved tumor regions, aiding in determining the optimal region for cell sampling and treatment options.
Tumor biopsies are an important aspect of oncology providing a guide for medical treatment and evaluation of disease progression. Highly heterogenous tumors have complex regions of active cancer cells interdigitated with necrotic tissue and healthy noncancerous tissue. The reliable access to tumor tissue pathology is therefore challenging and usually requires multiple needle insertions with accompanying patient discomfort and risk of infection. Oxygen levels provide a means of detecting and evaluating tumor tissue with levels reduced by 2-fold to 22-fold, depending on the type of organ. However, if the biopsy needle is placed in an area of normal tissue, there is always a chance that no diagnostic cells will be acquired for meaningful pathology and molecular analysis. While not the case in all tumors, there are cases where the in vivo oxygen levels differ with tumor cells having a value of pO(2) lying between the anoxic necrotic tissue and normoxic normal tissue. The level of oxygen in tumor cells can also vary with time as related to complex biochemical pathways. The efficacy of radiation therapy is also sensitive to oxygen levels in tumors. Lower levels of oxygen present greater resistance to treatment. To address these concerns, a pO(2)-guided biopsy needle (OGBN) was developed to determine oxygen levels and fluctuations in highly resolved regions of tumors, in order to aide in determining the optimal region for cell sampling help in determining medical treatment options.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据